11/2012
Aggressive fibromatosis is a benign fibroproliferative tumour that can occur as a sporadic lesion or a manifestation in patients with familial syndromes, such...
0992 | hedgehog signalling | 0571 | aggressive fibromatosis
0992 | hedgehog signalling | 0571 | aggressive fibromatosis
Dissertation
Pediatric Blood & Cancer, ISSN 1545-5009, 05/2018, Volume 65, Issue 5, pp. e26943 - n/a
Background Treatment algorithms for patients with aggressive fibromatosis (AF) are challenging. There are limited data available about the use of systemic...
children and adolescents | CWS Group | systemic therapy | aggressive fibromatosis | MANAGEMENT | EFFICACY | TNM CLASSIFICATION | METHOTREXATE | PHASE-II | BETA-CATENIN | TUMORS | CHILDHOOD | ONCOLOGY | DESMOID-TYPE FIBROMATOSIS | PEDIATRICS | HEMATOLOGY | SOFT-TISSUE SARCOMA | Fibromatosis, Aggressive - surgery | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Survival Rate | Combined Modality Therapy | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Adult | Female | Child | Fibromatosis, Aggressive - pathology | Fibromatosis, Aggressive - drug therapy | Infant, Newborn | Algorithms | Children | Health aspects | Analysis | Adolescence | Vinblastine | Complications | Clinical trials | Remission | Radiation therapy | Adolescents | Methotrexate | Patients | Survival | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Klinisk medicin
children and adolescents | CWS Group | systemic therapy | aggressive fibromatosis | MANAGEMENT | EFFICACY | TNM CLASSIFICATION | METHOTREXATE | PHASE-II | BETA-CATENIN | TUMORS | CHILDHOOD | ONCOLOGY | DESMOID-TYPE FIBROMATOSIS | PEDIATRICS | HEMATOLOGY | SOFT-TISSUE SARCOMA | Fibromatosis, Aggressive - surgery | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Survival Rate | Combined Modality Therapy | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Adult | Female | Child | Fibromatosis, Aggressive - pathology | Fibromatosis, Aggressive - drug therapy | Infant, Newborn | Algorithms | Children | Health aspects | Analysis | Adolescence | Vinblastine | Complications | Clinical trials | Remission | Radiation therapy | Adolescents | Methotrexate | Patients | Survival | Clinical Medicine | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Klinisk medicin
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 03/2018, Volume 100, Issue 4, pp. 997 - 1003
Radiation therapy (RT) is often used in the treatment of unresectable or recurrent aggressive fibromatosis (also known as desmoid tumor) typically with...
PHASE-II TRIAL | EFFICACY | ONCOLOGY | DESMOID-TYPE FIBROMATOSIS | IMATINIB | METHOTREXATE | VINBLASTINE | RADIOTHERAPY | SURGICAL-TREATMENT | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHILDREN | Medical records | Children | Radiotherapy | Health aspects | Analysis | Radiation | Index Medicus
PHASE-II TRIAL | EFFICACY | ONCOLOGY | DESMOID-TYPE FIBROMATOSIS | IMATINIB | METHOTREXATE | VINBLASTINE | RADIOTHERAPY | SURGICAL-TREATMENT | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHILDREN | Medical records | Children | Radiotherapy | Health aspects | Analysis | Radiation | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2018, Volume 36, Issue 2, pp. 202 - 209
In this review, we highlight the complexities of the natural history, biology, and clinical management of three intermediate connective tissue tumors: desmoid...
EFFICACY | ONCOLOGY | GIANT-CELL TUMOR | DESMOID-TYPE FIBROMATOSIS | DENOSUMAB | IMATINIB | METHOTREXATE | PHASE-II | BONE | EXPRESSION | VILLONODULAR SYNOVITIS | Outcome Assessment (Health Care) - methods | Fibromatosis, Aggressive - diagnostic imaging | Bone Neoplasms - therapy | Bone Neoplasms - diagnostic imaging | Humans | Magnetic Resonance Imaging - methods | Neoplasms, Connective Tissue - diagnostic imaging | Bone Neoplasms - pathology | Giant Cell Tumor of Tendon Sheath - diagnostic imaging | Fibromatosis, Aggressive - therapy | Giant Cell Tumor of Bone - therapy | Outcome Assessment (Health Care) - statistics & numerical data | Giant Cell Tumor of Bone - pathology | Giant Cell Tumor of Bone - diagnostic imaging | Giant Cell Tumor of Tendon Sheath - pathology | Giant Cell Tumor of Tendon Sheath - therapy | Neoplasms, Connective Tissue - therapy | Quality of Life | Neoplasms, Connective Tissue - pathology | Fibromatosis, Aggressive - pathology | Index Medicus | Sarcoma | Special Series
EFFICACY | ONCOLOGY | GIANT-CELL TUMOR | DESMOID-TYPE FIBROMATOSIS | DENOSUMAB | IMATINIB | METHOTREXATE | PHASE-II | BONE | EXPRESSION | VILLONODULAR SYNOVITIS | Outcome Assessment (Health Care) - methods | Fibromatosis, Aggressive - diagnostic imaging | Bone Neoplasms - therapy | Bone Neoplasms - diagnostic imaging | Humans | Magnetic Resonance Imaging - methods | Neoplasms, Connective Tissue - diagnostic imaging | Bone Neoplasms - pathology | Giant Cell Tumor of Tendon Sheath - diagnostic imaging | Fibromatosis, Aggressive - therapy | Giant Cell Tumor of Bone - therapy | Outcome Assessment (Health Care) - statistics & numerical data | Giant Cell Tumor of Bone - pathology | Giant Cell Tumor of Bone - diagnostic imaging | Giant Cell Tumor of Tendon Sheath - pathology | Giant Cell Tumor of Tendon Sheath - therapy | Neoplasms, Connective Tissue - therapy | Quality of Life | Neoplasms, Connective Tissue - pathology | Fibromatosis, Aggressive - pathology | Index Medicus | Sarcoma | Special Series
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue 10, pp. x158 - x166
Aggressive fibromatosis (AF) is a monoclonal proliferative disease but does not metastasize and does not dedifferentiate to a high-grade malignancy in case of...
Desmoid | Fibromatosis | fibromatosis | SURGERY | SOFT-TISSUE SARCOMAS | SERIES | PROGNOSTIC-FACTORS | FOLLOW-UP | AGGRESSIVE FIBROMATOSIS | RADIATION-THERAPY | PHASE | ONCOLOGY | IMATINIB | desmoid | ABDOMINAL-WALL | Adenomatous Polyposis Coli Protein - genetics | Neoplasm Recurrence, Local - radiotherapy | Humans | Neoplasm Recurrence, Local - drug therapy | Combined Modality Therapy | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | Biopsy | Protein Kinase Inhibitors - therapeutic use | Germ-Line Mutation | Retrospective Studies | Radiotherapy, Adjuvant | Fibromatosis, Aggressive - pathology
Desmoid | Fibromatosis | fibromatosis | SURGERY | SOFT-TISSUE SARCOMAS | SERIES | PROGNOSTIC-FACTORS | FOLLOW-UP | AGGRESSIVE FIBROMATOSIS | RADIATION-THERAPY | PHASE | ONCOLOGY | IMATINIB | desmoid | ABDOMINAL-WALL | Adenomatous Polyposis Coli Protein - genetics | Neoplasm Recurrence, Local - radiotherapy | Humans | Neoplasm Recurrence, Local - drug therapy | Combined Modality Therapy | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | Biopsy | Protein Kinase Inhibitors - therapeutic use | Germ-Line Mutation | Retrospective Studies | Radiotherapy, Adjuvant | Fibromatosis, Aggressive - pathology
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 51, Issue 2, pp. 127 - 136
Abstract Desmoid-type fibromatosis (DF) is a rare monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course....
Hematology, Oncology and Palliative Medicine | Patient advocacy groups | SPAEN | Consensus | Treatment algorithm | Desmoid-type fibromatosis | EORTC/STBSG | REGRESSION | PROGNOSTIC-FACTORS | SEE POLICY | AGGRESSIVE FIBROMATOSIS | TUMORS | RADIATION-THERAPY | PHASE-II TRIAL | LOCAL RECURRENCE | ONCOLOGY | IMATINIB | MUTATION | Fibromatosis, Aggressive - diagnosis | Bone Neoplasms - therapy | Fibromatosis, Aggressive - prevention & control | Europe | Humans | Osteosarcoma - prevention & control | Patient Care Management - methods | Sarcoma - therapy | Fibromatosis, Aggressive - therapy | Algorithms | Bone Neoplasms - prevention & control | Biomedical Research - methods | Sarcoma - prevention & control | Osteosarcoma - therapy | Patient Care Management - organization & administration | Medicine, Experimental | Medical research | Care and treatment | Sarcoma
Hematology, Oncology and Palliative Medicine | Patient advocacy groups | SPAEN | Consensus | Treatment algorithm | Desmoid-type fibromatosis | EORTC/STBSG | REGRESSION | PROGNOSTIC-FACTORS | SEE POLICY | AGGRESSIVE FIBROMATOSIS | TUMORS | RADIATION-THERAPY | PHASE-II TRIAL | LOCAL RECURRENCE | ONCOLOGY | IMATINIB | MUTATION | Fibromatosis, Aggressive - diagnosis | Bone Neoplasms - therapy | Fibromatosis, Aggressive - prevention & control | Europe | Humans | Osteosarcoma - prevention & control | Patient Care Management - methods | Sarcoma - therapy | Fibromatosis, Aggressive - therapy | Algorithms | Bone Neoplasms - prevention & control | Biomedical Research - methods | Sarcoma - prevention & control | Osteosarcoma - therapy | Patient Care Management - organization & administration | Medicine, Experimental | Medical research | Care and treatment | Sarcoma
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2011, Volume 29, Issue 26, pp. 3553 - 3558
Purpose Desmoid tumors are mesenchymal fibroblastic/myofibroblastic proliferations with locoregional aggressiveness and high ability to recur after initial...
SURGERY | FOLLOW-UP | AGGRESSIVE FIBROMATOSIS | MANAGEMENT | ONCOLOGY | RADIATION-THERAPY | Fibromatosis, Aggressive - diagnosis | Multivariate Analysis | Prognosis | Europe | Humans | Middle Aged | Child, Preschool | Infant | Male | Fibromatosis, Aggressive - therapy | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child
SURGERY | FOLLOW-UP | AGGRESSIVE FIBROMATOSIS | MANAGEMENT | ONCOLOGY | RADIATION-THERAPY | Fibromatosis, Aggressive - diagnosis | Multivariate Analysis | Prognosis | Europe | Humans | Middle Aged | Child, Preschool | Infant | Male | Fibromatosis, Aggressive - therapy | Adolescent | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | Child
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2012, Volume 23, Issue 3, pp. 562 - 569
Desmoid tumors (DTs) are histologically benign proliferations of stromal cells but may grow locally aggressive. Overall, DTs are rare (0.03% of all neoplasms)....
Desmoid tumors | Aggressive fibromatosis | Treatment | Diagnosis | treatment | GENOTYPE-PHENOTYPE CORRELATIONS | PROGNOSTIC-FACTORS | diagnosis | CATENIN MUTATIONS | desmoid tumors | RADIATION-THERAPY | ESTROGEN-RECEPTOR-BETA | ONCOLOGY | APC GENE | FAMILIAL ADENOMATOUS POLYPOSIS | EXPRESSION | aggressive fibromatosis | IMATINIB MESYLATE | Fibromatosis, Aggressive - diagnosis | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | Humans
Desmoid tumors | Aggressive fibromatosis | Treatment | Diagnosis | treatment | GENOTYPE-PHENOTYPE CORRELATIONS | PROGNOSTIC-FACTORS | diagnosis | CATENIN MUTATIONS | desmoid tumors | RADIATION-THERAPY | ESTROGEN-RECEPTOR-BETA | ONCOLOGY | APC GENE | FAMILIAL ADENOMATOUS POLYPOSIS | EXPRESSION | aggressive fibromatosis | IMATINIB MESYLATE | Fibromatosis, Aggressive - diagnosis | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | Humans
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2007, Volume 34, Issue 4, pp. 462 - 468
Abstract Objective To evaluate the impact of surgery as first-line treatment on event-free survival (EFS) of primary aggressive fibromatosis. Patients and...
Hematology, Oncology and Palliative Medicine | Surgery | Aggressive fibromatosis | Desmoid tumour | Soft tissue tumour | soft tissue tumour | RE-EXCISION | desmoid rumour | PROLIFERATION | MARGINS | RADIATION-THERAPY | ONCOLOGY | EXTREMITY | ADJUVANT RADIOTHERAPY | MUTATIONS | aggressive fibromatosis | SOFT-TISSUE SARCOMA | surgery | DESMOID TUMORS | Fibromatosis, Aggressive - surgery | Humans | Middle Aged | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Fibromatosis, Aggressive - therapy | Soft Tissue Neoplasms - surgery | Adolescent | Soft Tissue Neoplasms - pathology | Survival Analysis | Adult | Female | Aged | Radiotherapy, Adjuvant | Child | Fibromatosis, Aggressive - pathology | Soft Tissue Neoplasms - therapy
Hematology, Oncology and Palliative Medicine | Surgery | Aggressive fibromatosis | Desmoid tumour | Soft tissue tumour | soft tissue tumour | RE-EXCISION | desmoid rumour | PROLIFERATION | MARGINS | RADIATION-THERAPY | ONCOLOGY | EXTREMITY | ADJUVANT RADIOTHERAPY | MUTATIONS | aggressive fibromatosis | SOFT-TISSUE SARCOMA | surgery | DESMOID TUMORS | Fibromatosis, Aggressive - surgery | Humans | Middle Aged | Child, Preschool | Infant | Male | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Fibromatosis, Aggressive - therapy | Soft Tissue Neoplasms - surgery | Adolescent | Soft Tissue Neoplasms - pathology | Survival Analysis | Adult | Female | Aged | Radiotherapy, Adjuvant | Child | Fibromatosis, Aggressive - pathology | Soft Tissue Neoplasms - therapy
Journal Article
The Oncologist, ISSN 1083-7159, 05/2011, Volume 16, Issue 5, pp. 682 - 693
Desmoid tumors describe a rare monoclonal, fibroblastic proliferation characterized by a variable and often unpredictable clinical course. Although...
Advanced disease | Aggressive fibromatosis | β‐catenin | Individualized treatment | Desmoid tumor | β-catenin | beta-catenin | SOFT-TISSUE SARCOMAS | MANAGEMENT | GENOTYPE-PHENOTYPE CORRELATIONS | ISOLATED LIMB PERFUSION | RADIATION-THERAPY | ONCOLOGY | GRADE FIBROMYXOID SARCOMA | APC GENE | FAMILIAL ADENOMATOUS POLYPOSIS | Adenomatous Polyposis Coli Protein - genetics | Diagnosis, Differential | Humans | Combined Modality Therapy | Fibromatosis, Abdominal - therapy | beta Catenin - genetics | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | DNA Mutational Analysis | Fibromatosis, Abdominal - pathology | Mesentery - pathology | Neoplasm Staging | Fibromatosis, Aggressive - pathology | Sarcomas
Advanced disease | Aggressive fibromatosis | β‐catenin | Individualized treatment | Desmoid tumor | β-catenin | beta-catenin | SOFT-TISSUE SARCOMAS | MANAGEMENT | GENOTYPE-PHENOTYPE CORRELATIONS | ISOLATED LIMB PERFUSION | RADIATION-THERAPY | ONCOLOGY | GRADE FIBROMYXOID SARCOMA | APC GENE | FAMILIAL ADENOMATOUS POLYPOSIS | Adenomatous Polyposis Coli Protein - genetics | Diagnosis, Differential | Humans | Combined Modality Therapy | Fibromatosis, Abdominal - therapy | beta Catenin - genetics | Fibromatosis, Aggressive - genetics | Fibromatosis, Aggressive - therapy | DNA Mutational Analysis | Fibromatosis, Abdominal - pathology | Mesentery - pathology | Neoplasm Staging | Fibromatosis, Aggressive - pathology | Sarcomas
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, pp. 4028 - 4035
Desmoid tumors are rare and exhibit a highly unpredictable natural history. We sought to analyze prognostic factors associated with recurrence in a large...
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | TRUNK | MANAGEMENT | ONCOLOGY | EXTREMITY | AGGRESSIVE FIBROMATOSIS | ADJUVANT RADIOTHERAPY | RADIATION-THERAPY | Fibromatosis, Aggressive - mortality | Prognosis | Follow-Up Studies | Humans | Neoplasm Recurrence, Local - therapy | Male | Survival Rate | Combined Modality Therapy | Fibromatosis, Abdominal - therapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Fibromatosis, Aggressive - therapy | Fibromatosis, Abdominal - pathology | Adult | Female | Fibromatosis, Abdominal - mortality | Retrospective Studies | Radiotherapy, Adjuvant | Fibromatosis, Aggressive - pathology | Postoperative Complications | Nuclear radiation | Analysis | Risk factors | Tumors
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | TRUNK | MANAGEMENT | ONCOLOGY | EXTREMITY | AGGRESSIVE FIBROMATOSIS | ADJUVANT RADIOTHERAPY | RADIATION-THERAPY | Fibromatosis, Aggressive - mortality | Prognosis | Follow-Up Studies | Humans | Neoplasm Recurrence, Local - therapy | Male | Survival Rate | Combined Modality Therapy | Fibromatosis, Abdominal - therapy | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Fibromatosis, Aggressive - therapy | Fibromatosis, Abdominal - pathology | Adult | Female | Fibromatosis, Abdominal - mortality | Retrospective Studies | Radiotherapy, Adjuvant | Fibromatosis, Aggressive - pathology | Postoperative Complications | Nuclear radiation | Analysis | Risk factors | Tumors
Journal Article
Gut, ISSN 0017-5749, 05/2008, Volume 57, Issue 5, pp. 704 - 713
Background: Familial adenomatous polyposis (FAP) is a well-described inherited syndrome, which is responsible for <1% of all colorectal cancer (CRC) cases. The...
RESTORATIVE PROCTOCOLECTOMY | GERMLINE MUTATIONS | THYROID-CARCINOMA | AGGRESSIVE FIBROMATOSIS | MUTYH-ASSOCIATED POLYPOSIS | ILEAL POUCH | GASTROENTEROLOGY & HEPATOLOGY | CYCLOOXYGENASE-2 INHIBITOR | POUCH-ANAL ANASTOMOSIS | DESMOID TUMORS | COLORECTAL ADENOMAS | Fibromatosis, Aggressive - diagnosis | Genetic Predisposition to Disease | Humans | Risk Factors | Male | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Genetic Testing - methods | Genes, APC | Fibromatosis, Aggressive - therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Age of Onset | Female | Adenomatous Polyposis Coli - therapy | Adenomatous Polyposis Coli - genetics | Adenomatous Polyposis Coli - diagnosis | Prevention | Evaluation | Care and treatment | Colorectal cancer | Practice guidelines (Medicine) | Polyposis, Familial | Risk factors | Studies | Mutation | Genes | Medical protocols | Polyps (Pathology) | Intestines | Intestins | Intestinal diseases | Malalties intestinals | Pòlips (Patologia)
RESTORATIVE PROCTOCOLECTOMY | GERMLINE MUTATIONS | THYROID-CARCINOMA | AGGRESSIVE FIBROMATOSIS | MUTYH-ASSOCIATED POLYPOSIS | ILEAL POUCH | GASTROENTEROLOGY & HEPATOLOGY | CYCLOOXYGENASE-2 INHIBITOR | POUCH-ANAL ANASTOMOSIS | DESMOID TUMORS | COLORECTAL ADENOMAS | Fibromatosis, Aggressive - diagnosis | Genetic Predisposition to Disease | Humans | Risk Factors | Male | Duodenal Neoplasms - therapy | Duodenal Neoplasms - diagnosis | Genetic Testing - methods | Genes, APC | Fibromatosis, Aggressive - therapy | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Age of Onset | Female | Adenomatous Polyposis Coli - therapy | Adenomatous Polyposis Coli - genetics | Adenomatous Polyposis Coli - diagnosis | Prevention | Evaluation | Care and treatment | Colorectal cancer | Practice guidelines (Medicine) | Polyposis, Familial | Risk factors | Studies | Mutation | Genes | Medical protocols | Polyps (Pathology) | Intestines | Intestins | Intestinal diseases | Malalties intestinals | Pòlips (Patologia)
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2005, Volume 61, Issue 3, pp. 882 - 891
After a general Patterns of Care Study (PCS) the German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) initiated a multicenter cohort study to...
Desmoid tumors | Patterns of Care Study | Aggressive fibromatosis | Benign disease | Radiotherapy | Surgery | MANAGEMENT | patterns of care study | desmoid tumors | MUSCULO-APONEUROTIC FIBROMATOSIS | LOW-DOSE CHEMOTHERAPY | SOFT-TISSUE | COMBINED SURGERY | GARDNERS-SYNDROME | ONCOLOGY | benign disease | radiotherapy | LOCAL-CONTROL | EXPERIENCE | ADJUVANT RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | aggressive fibromatosis | BENIGN DISEASES | surgery | Radiotherapy Dosage | Humans | Female | Male | Surveys and Questionnaires | Treatment Outcome | Statistics as Topic | Germany | Health Care Surveys | Fibromatosis, Aggressive - radiotherapy | Health aspects | Analysis | Radiation | SURGERY | IRRADIATION | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | EVALUATION | TOXICITY | RADIOTHERAPY | SIDE EFFECTS | DOSE-RESPONSE RELATIONSHIPS
Desmoid tumors | Patterns of Care Study | Aggressive fibromatosis | Benign disease | Radiotherapy | Surgery | MANAGEMENT | patterns of care study | desmoid tumors | MUSCULO-APONEUROTIC FIBROMATOSIS | LOW-DOSE CHEMOTHERAPY | SOFT-TISSUE | COMBINED SURGERY | GARDNERS-SYNDROME | ONCOLOGY | benign disease | radiotherapy | LOCAL-CONTROL | EXPERIENCE | ADJUVANT RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | aggressive fibromatosis | BENIGN DISEASES | surgery | Radiotherapy Dosage | Humans | Female | Male | Surveys and Questionnaires | Treatment Outcome | Statistics as Topic | Germany | Health Care Surveys | Fibromatosis, Aggressive - radiotherapy | Health aspects | Analysis | Radiation | SURGERY | IRRADIATION | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | EVALUATION | TOXICITY | RADIOTHERAPY | SIDE EFFECTS | DOSE-RESPONSE RELATIONSHIPS
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2016, Volume 42, Issue 7, pp. 1071 - 1083
Abstract Extra abdominal desmoid fibromatosis is a complex condition with many recognised treatments including active observation, hormonal therapy,...
Hematology, Oncology and Palliative Medicine | Surgery | Review | Management | Aggressive | Extra-abdominal | Desmoid | Fibromatosis | SURGERY | WALL | PROGNOSTIC-FACTORS | AGGRESSIVE FIBROMATOSIS | LOW-DOSE CHEMOTHERAPY | TUMORS | RADIATION-THERAPY | ONCOLOGY | FRENCH SARCOMA GROUP | COMBINATION CHEMOTHERAPY | RECURRENCE | SURGICAL RESECTION | Fibroma - diagnosis | Fibromatosis, Aggressive - diagnosis | Biopsy, Needle - instrumentation | Chromosomes, Human, Pair 8 - genetics | Fibromatosis, Aggressive - diagnostic imaging | Prognosis | Biomarkers, Tumor - analysis | Humans | Risk Factors | Fibroma - therapy | Patient Care Team | Clinical Trials as Topic | Molecular Targeted Therapy | Biopsy, Needle - methods
Hematology, Oncology and Palliative Medicine | Surgery | Review | Management | Aggressive | Extra-abdominal | Desmoid | Fibromatosis | SURGERY | WALL | PROGNOSTIC-FACTORS | AGGRESSIVE FIBROMATOSIS | LOW-DOSE CHEMOTHERAPY | TUMORS | RADIATION-THERAPY | ONCOLOGY | FRENCH SARCOMA GROUP | COMBINATION CHEMOTHERAPY | RECURRENCE | SURGICAL RESECTION | Fibroma - diagnosis | Fibromatosis, Aggressive - diagnosis | Biopsy, Needle - instrumentation | Chromosomes, Human, Pair 8 - genetics | Fibromatosis, Aggressive - diagnostic imaging | Prognosis | Biomarkers, Tumor - analysis | Humans | Risk Factors | Fibroma - therapy | Patient Care Team | Clinical Trials as Topic | Molecular Targeted Therapy | Biopsy, Needle - methods